Air Voel Expands Product Line with the Latest ResMed CPAP Machines for Enhanced Sleep Therapy.Canada - November 8, 2024 — Air ...

Air Voel believes in sleep health, offering cutting-edge CPAP devices that are reliable and adjustable for restful sleep. Air Voel allows people to manage their health with innovative technology, ...

Sleep apnoea affects many older Australians — but managing it isn’t as difficult or expensive as you might think.

The most significant challenge facing ResMed is the potential impact of GLP-1 drugs on its core CPAP device market. Eli Lilly (NYSE:LLY)'s tirzepatide, a GLP-1 medication, is expected to receive ...

Q1 2025 Earnings Call Transcript October 24, 2024 ResMed Inc. beats earnings expectations. Reported EPS is $2.2, expectations ...

But the central driver of the investment thesis is ResMed's market for sleep apnoea devices, particularly continuous positive airway pressure (CPAP) machines. Put bluntly, the market size is huge ...

Hello, and welcome to the Q1 fiscal year 2025 ResMed Earnings conference call. My name is Kevin, and I'll be your operator for today's call. (Operator Instructions) Please note this conference call is ...

as patients become more aware of the disease and doctors use all tools to treat the disease, including ResMed’s CPAP devices.

ResMed stock broke out early Friday after the CPAP maker broadly beat third-quarter projections. Please watch the video at Investors.com - S&P 500 Giants Report Earnings. Will Megacap Results ...